Bayer will offer testing with Veracyte’s RNA sequencing-based Afirma XA to identify underlying genomic drivers of thyroid cancer

December 24, 2020 Leave a comment 4,646 Views

Bayer and Veracyte today announced a new collaboration to advance the Precision Oncology Patient Identification Program in thyroid cancer. Through the program, Bayer will offer testing with...

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

May 7, 2020 Leave a comment 1,619 Views

Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Bayer

Bayer will offer testing with Veracyte’s RNA sequencing-based Afirma XA to identify underlying genomic drivers of thyroid cancer

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

Learning to predict RNA sequence expressions from whole slide images

CRIC-seq – global profiling of in-situ RNA–RNA contacts associated with a specific RNA-binding protein

Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform

Long noncoding RNA profiling may be effective for stratification in pediatric AML

spSeudoMap – cell type mapping of spatial transcriptomics using unmatched single-cell RNA-seq data

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit